Ragavendra Baliga/LinkedIn
May 9, 2026, 14:38
Ragavendra Baliga: This Week’s 3 Major Trials to Reshape Adjunctive Reperfusion Strategies in Acute Ischemic Stroke
Ragavendra Baliga, Editor-In-Chief of the Textbook of Internal Medicine, Professor of Internal Medicine and Faculty Cardiologist at The Ohio State University Wexner Medical Center, shared on LinkedIn:
”Three major stroke trials published in JAMA this week may reshape adjunctive reperfusion strategies in acute ischemic stroke.
- TNK-PLUS: Tenecteplase before thrombectomy in late-window stroke showed no added functional benefit.
- CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent neurological recovery, though mortality signals warrant caution.
- INSTANT: Early tirofiban after inadequate tenecteplase response significantly improved 90-day outcomes in non-large vessel occlusion stroke.
Together, these studies highlight a growing shift from merely reopening arteries toward optimizing microvascular reperfusion and tissue recovery.”
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments